Vanrx Pharmasystems
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Angel | ||
* | N/A | Acquisition | |
Total Funding | - |
Related Content
Recent News about Vanrx Pharmasystems
EditVanrx, now part of Cytiva, specializes in developing advanced aseptic filling machines known as Aseptic Filling Workcells. These machines are designed to fill vials, syringes, and cartridges with biopharmaceutical products in a sterile environment, ensuring the safety and efficacy of the drugs. Vanrx serves clients in the biopharmaceutical industry, including major companies like Roche Genentech, Moderna, and FUJIFILM Diosynth. The company operates in the biopharma manufacturing market, focusing on providing flexible and automated solutions that meet the unique needs of modern therapeutics. Vanrx's business model revolves around selling these high-tech filling machines and offering related services, generating revenue through equipment sales and maintenance contracts. The company's innovative technology helps reduce risks and speeds up the time-to-market for new drugs, making it a valuable partner for biopharma companies aiming to bring their products to patients faster.
Keywords: Aseptic Filling, Biopharma, Vials, Syringes, Cartridges, Automation, Flexibility, Drug Delivery, Sterile Manufacturing, Therapeutics.